Trial Details
COMPLETEDBasic Information
| Clinical ID | c2470 |
|---|---|
| Identifier | NCT03452501 |
| Trial Title | Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Crohn Disease|Fistulizing Crohn's Disease|Ulcerative Colitis |
| Interventions | DRUG: Infliximab |
Participant Information
| Sponsor | Hikma Pharmaceuticals LLC |
|---|---|
| City | Jeddah |
| Country/Region | Saudi Arabia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2018-08-26 |
|---|---|
| Primary Completion Date | 2020-08-17 |
| Completion Date | 2020-08-17 |